Table 3.
Clinical outcome (secondary outcome) of the patients
| Total 53 (100%) | Enoxaparin group 26 (100%) | Placebo group 27 (100%) | P | |
|---|---|---|---|---|
| GOS | ||||
| Good recovery | 15 (28.3) | 13 (50.0) | 2 (7.4) | 0.006 |
| Moderate disability | 7 (13.2) | 2 (7.7) | 5 (18.5) | |
| Severe disability | 14 (26.4) | 7 (26.9) | 7 (25.9) | |
| Vegetative state | 11 (20.8) | 2 (7.7) | 9 (33.3) | |
| Death | 6 (11.3) | 2 (7.7) | 4 (14.8) | |
| Favorable outcome | 22 (41.5) | 15 (57.7) | 7 (25.9) | 0.019 |
| Hospital stay duration | 27.3±14 | 24.4±12.1 | 30.1±15.4 | 0.138 |
| ICU stay duration | 22.2±13.3 | 19.3±13.2 | 25.0±13.1 | 0.119 |
GOS=Glasgow Outcome Scale